Abstract
Hemostatic problems brought on by coagulopathy and thrombocytopenia are common in patients with acute leukemia. Coagulopathy can result in considerable morbidity and death and makes patient treatment more difficult. The purpose of this guidance document is to review and offer recommendations regarding the management of hemostatic complications in adult patients with acute leukemia. It addresses four primary concerns: the use of antifibrinolytic agents; platelet transfusion; disseminated intravascular coagulation; and hypofibrinogenemia related to L-asparaginase.
Keywords
patient
hemostatic complications
blood
cure
diagnosis
treatment
medication